Lactate Promotes Endothelial-Mesenchymal Transition via Mediating Twist1 Lactylation in Hypoxic Pulmonary Hypertension
International Journal of Molecular Sciences · 27.02.2026 · 27 (5) · 2255
DOI: 10.3390/ijms27052255 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.02.2026. Verfasst von Xingbing Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Cardiovascular Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 40001…. Hauptthemen laut MEDLINE: Endothelial-Mesenchymal Transition, Twist-Related Protein 1, Hypertension, Pulmonary, Hypoxia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Program of the Chongqing Natural Science Foundation, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Elevated plasma lactate is a significant risk factor in pulmonary hypertension (PH), and endothelial-mesenchymal transition (EndoMT) is a major contributor to this pathological process, yet its specific role in driving endothelial-mesenchymal transition (EndoMT) remains unclear. Using in vivo and in vitro models, we demonstrate that modulating lactate levels critically influences PH progression. In a hypoxic PH mouse model, inhibition of lactate production ameliorated hemodynamic and vascular remodeling, whereas exogenous lactate exacerbated these pathologies. In human pulmonary arterial endothelial cells under hypoxia, lactate promoted a pro-remodeling phenotype, enhancing migration, proliferation, and EndoMT. Mechanistically, lactate induced Twist1 lactylation via enhanced association with p300/CBP, promoting its nuclear translocation. This upregulated TGFB1 transcription and activated the Smad2 pathway, thereby driving EndoMT—an effect abolished by Twist1 knockdown. Our findings reveal a previously unrecognized lactate-Twist1 lactylation-TGFB1 axis that promotes vascular remodeling in PH, identifying novel therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Cardiovascular Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
- Department of Cardiology, The Third Military Medical University, Chongqing 400042, China.
- School of Pharmacy and Biological Engineering, Chongqing University of Technology, Chongqing 400054, China.
- Chongqing Key Laboratory for Pharmaceutical Metabolism Research, College of Pharmacy, Chongqing Medical University, Chongqing 400016, China.
ORCID-Profile: Xingbing Li, Ningxin Liu, Ming Tang
Förderung
- General Program of the Chongqing Natural Science Foundation
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Wang, F., Liu, N., Liu, Y., Yu, W., & Tang, M. (2026). Lactate Promotes Endothelial-Mesenchymal Transition via Mediating Twist1 Lactylation in Hypoxic Pulmonary Hypertension. International Journal of Molecular Sciences, 27(5), 2255. https://doi.org/10.3390/ijms27052255
Vancouver
Li X, Wang F, Liu N, Liu Y, Yu W, Tang M. Lactate Promotes Endothelial-Mesenchymal Transition via Mediating Twist1 Lactylation in Hypoxic Pulmonary Hypertension. International Journal of Molecular Sciences. 2026;27(5):2255. doi:10.3390/ijms27052255
BibTeX
@article{Li2026,
author = {Li, Xingbing and Wang, Fengxian and Liu, Ningxin and Liu, Yu and Yu, Weimin and Tang, Ming},
title = {Lactate Promotes Endothelial-Mesenchymal Transition via Mediating Twist1 Lactylation in Hypoxic Pulmonary Hypertension},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2255},
doi = {10.3390/ijms27052255}
}
EUVIMED